Atlas Trials

A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children

Clinical trial NCT01091246 · COMPLETED

Trial details

NCT number
NCT01091246
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Healthy or Stable Chronic Illness
Start date
2010-03-01
Primary completion
2010-07-01
Enrollment
2312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.